Classification
- Anatomical main groupAAlimentary tract and metabolism
- Therapeutic subgroupA10
- Pharmacological subgroupA10B
- Chemical subgroupA10BJ
- Chemical substanceA10BJ01Exenatide
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Spain
AEMPS · 5 registrations
- Bydureon 2 MG Polvo y Disolvente Para Suspension Inyectable de Liberacion Prolongada2 mg · polvo y disolvente para suspensión inyectable de liberación prolongada · Astrazeneca Ab
- Bydureon 2 MG Polvo y Disolvente Para Suspension Inyectable de Liberacion Prolongada en Pluma Precargada2 mg · polvo y disolvente para suspensión inyectable de liberación prolongada · Astrazeneca Ab
- Bydureon 2 MG Suspension Inyectable de Liberacion Prolongada en Pluma Precargada2,6 mg · suspension inyectable de liberacion prolongada · Astrazeneca Ab
- Byetta 10 Microgramos Solucion Inyectable en Pluma Precargada0,25 mg · solución inyectable en pluma precargada · Astrazeneca Ab
Netherlands
At a glance
- ATC code
- A10BJ01
- ATC group
- Alimentary tract and metabolism
- Registers
- 5
- Historical lists
- 2
- Registrations
- 27
- With their own page
- 7
- Companies
- 7
All medicines with Exenatide
Human medicines from every register that match Exenatide by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
32 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Exenatide Synthetic | United States | 300MCG/1.2ML, 600MCG/2.4ML | injectable | Marketed | Amneal |
| Bydureon | European Union | Authorised | AstraZeneca AB | ||
| Byetta | European Union | Authorised | AstraZeneca AB | ||
| Bydureon 2 mg poeder en oplosmiddel voor suspensie voor injectie met verlengde afgifte | Netherlands | Poeder en oplosmiddel voor suspensie voor injectie met verlengde afgifte | Authorised | AstraZeneca AB | |
| Bydureon 2 mg poeder en oplosmiddel voor suspensie voor injectie met verlengde afgifte voor injectie in voorgevulde pen | Netherlands | Poeder en oplosmiddel voor suspensie voor injectie met verlengde afgifte | Authorised | AstraZeneca AB | |
| Byetta, 5 microgram, oplossing voor injectie in voorgevulde pen | Netherlands | Oplossing voor injectie | Authorised | AstraZeneca AB | |
| Byetta, 10 microgram, oplossing voor injectie in voorgevulde pen | Netherlands | Oplossing voor injectie | Authorised | AstraZeneca AB | |
| Bydureon 2 mg suspensie met verlengde afgifte voor injectie in voorgevulde pen | Netherlands | Suspensie voor injectie | Authorised | AstraZeneca AB | |
| Byetta | United States | 300MCG/1.2ML, 300UGM/1.2ML, 600MCG/2.4ML … | injectable | Marketed | Astrazeneca AB |
| Bydureon | United States | 2MG/VIAL | for suspension, extended release | Not marketed | Astrazeneca AB |
| Bydureon Bcise | United States | 2MG/0.85ML | suspension, extended release | Not marketed | Astrazeneca AB |
| Bydureon Pen | United States | 2MG | for suspension, extended release | Not marketed | Astrazeneca AB |
| BYETTA 10 mcg/ml solution for injection pre-filled pen | Saudi Arabia | Authorised | Baxter Pharmaceutical Solution LLC | ||
| Byetta 250 MCG/ML Pre - Fiied Pen | Saudi Arabia | Authorised | Baxter Pharmaceutical Solution LLC | ||
| Byetta 250 MCG/ML Pre - Fiied Pen | Saudi Arabia | Authorised | Baxter Pharmaceutical Solution LLC | ||
| BYETTA 5 mcg/ml solution for injection pre-filled pen | Saudi Arabia | Authorised | Baxter Pharmaceutical Solution LLC | ||
| Bydureon 2 MG Suspension Inyectable de Liberacion Prolongada en Pluma Precargada | Spain | 2,6 mg | suspension inyectable de liberacion prolongada | Withdrawn | Astrazeneca Ab |
| Bydureon 2 MG Polvo y Disolvente Para Suspension Inyectable de Liberacion Prolongada en Pluma Precargada | Spain | 2 mg | polvo y disolvente para suspensión inyectable de liberación prolongada | Withdrawn | Astrazeneca Ab |
| Byetta 5 Microgramos Solucion Inyectable en Pluma Precargada | Spain | 0,25 mg | solución inyectable en pluma precargada | Withdrawn | Astrazeneca Ab |
| Byetta 10 Microgramos Solucion Inyectable en Pluma Precargada | Spain | 0,25 mg | solución inyectable en pluma precargada | Withdrawn | Astrazeneca Ab |
| Bydureon 2 MG Polvo y Disolvente Para Suspension Inyectable de Liberacion Prolongada | Spain | 2 mg | polvo y disolvente para suspensión inyectable de liberación prolongada | Withdrawn | Astrazeneca Ab |
| Bydureon | Brazil | Cancelled | Astrazeneca do Brasil Ltda | ||
| Bydureon | Canada | 2 MG / DOSE | Kit, Powder For Suspension (Sustained-Release | Cancelled | Astrazeneca Canada INC |
| BYDUREON 2 mg | Romania | 2 mg | susp. inj. cu elib. in stilou injector ( pen) | Status unknown | Astrazeneca AB |
| Bydureon Bcise | Canada | 2 MG / DOSE | Suspension (Extended-Release) | Cancelled | Astrazeneca Canada INC |